[1]
|
Ohta M, Inoue H, Cotticelli WG, et al.The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t (3; 8) breakpoint, is abnormal in digestive tract cancers[J].Cell, 1996, 84(4):587-597. |
[2]
|
Sard L, Accornero P, Tornielli S, et al.The tumorsuppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control[J].Proc Natl Acad Sci USA, 1999, 96(15):8489-8492. |
[3]
|
Ji L, Fang B, Yen N, et al.Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression[J].Cancer Res, 1999, 59(14):3333-3339. |
[4]
|
Barnes LD, Garrison PN, Siprashvili Z, et al.Fhit, a putative tumor suppressor in humans, is a dinucleoside 5', 5'''-P1, P3-triphosphate hydrolase[J].Biochemistry, 1996, 35(36):11529-11535. |
[5]
|
Siprashvili Z, Sozzi G, Barnes LD, et al.Replacement of Fhit in cancer cells suppresses tumorigenicity[J].Proc Natl Acad Sci USA, 1997, 94(25):13771-13776. |
[6]
|
Pace HC, Garrison PN, Robinson AK, et al.Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit[J].Proc Natl Acad Sci USA, 1998, 95(10):5484-5489. |
[7]
|
Morikawa H, Nakagawa Y, Hashimoto K, et al.Frequent altered expression of fragile histidine triad protein in human colorectal adenomas[J].Biochcm Biophys Res Comrmn, 2000, 278(1):205-210. |
[8]
|
Otterson GA, Xiao GH, Geradts J, et al.Protein expression and functional analysis of the FHIT gene in human tumor cells[J].J Natl Cancer Inst, 1998, 90(6):426-432. |
[9]
|
Pekarsky Y, Campiglio M, Siprashvili Z, et al.Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans[J].Proc Natl Acad Sci USA, 1998, 95(15):8744-8749. |
[10]
|
Garinis GA, Gorgoulis VG, Mariatos G, et al.Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromesomal instability in non-small cell lung carcinomas (NSCLCs)[J].JPathol, 2001, 193(1):55-65. |
[11]
|
Gemma A, Hagiwara K, Ke Y, et al.FHIT mutations in human primary gastric cancer[J].Cancer Res, 1997, 57(8):1435-1437. |
[12]
|
Sozzi G, Veronese ML, Negrini M, et al.The FHIT gene 3p14.2 is abnormal in lung cancer[J].Cell, 1996, 85(1):17-26. |
[13]
|
Sozzi G, Sard L, De Gregorio L, et al.Association between cigarette smoking and FHIT gene alterations in lung cancer[J].Cancer Res, 1997, 57(11):2121-2123. |
[14]
|
Nelson HH, Wiencke JK, Gunn L, et al.Chromosome 3p14 alterations in lung cancer evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos[J].Cancer Res, 1998, 58(9):1804-1807. |
[15]
|
Fang JM, Arlt MF, Burgess AC, et al.Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma[J].Genes Chromosomes Cancer, 2001, 30(3):292-298. |
[16]
|
Campiglio M, Pekarsky Y, Menard S, et al.FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease[J].Cancer Res, 1999, 59(16):3866-3869. |
[17]
|
Huiping C, Jonasson JG, Agnarsson BA, et al.Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancer[J].Eur J Cancer, 2000, 36(12):1552-1557. |
[18]
|
Baffa R, Gomella LG, Vecchione A, et al.Loss of FHIT expression in transitional cell carcinoma of the urinary hladder[J].Am J Pathol, 2000, 156(2):419-424. |
[19]
|
Louhelainen J, Wijkstrom H, Hemminki K, et al.Multiple regions with allelic loss at chromosome 3 in superficial multifocal bladder tumors[J].Int J Oncol, 2001, 18(1):201-210. |
[20]
|
Dano L, Guilly MN, Muleris M, et al.CGH analysis of radon-induced rat lung tumors indicates similarities with human lung cancers[J].Genes Chromosomes Cancer, 2000, 29(1):1-8. |